Cubist Systematic Strategies’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $184K | Sell |
109,226
-242,879
| -69% | -$393K | ﹤0.01% | 2675 |
|
|
2025
Q2 | $426K | Buy |
+352,105
| New | +$511K | ﹤0.01% | 2312 |
|
|
2025
Q1 | – | Sell |
-111,993
| Closed | -$364K | – | 3245 |
|
|
2024
Q4 | $364K | Buy |
+111,993
| New | +$403K | ﹤0.01% | 2316 |
|
|
2024
Q2 | – | Sell |
-116,317
| Closed | -$1.71M | – | 3618 |
|
|
2024
Q1 | $1.71M | Buy |
116,317
+71,314
| +158% | +$1.08M | 0.01% | 1767 |
|
|
2023
Q4 | $433K | Buy |
+45,003
| New | +$311K | ﹤0.01% | 2595 |
|
|
2023
Q2 | – | Sell |
-146,232
| Closed | -$1.05M | – | 3986 |
|
|
2023
Q1 | $1.05M | Sell |
146,232
-140,647
| -49% | -$847K | 0.01% | 2150 |
|
|
2022
Q4 | $1.92M | Buy |
286,879
+109,214
| +61% | +$599K | 0.01% | 1890 |
|
|
2022
Q3 | $615K | Buy |
177,665
+3,912
| +2% | +$15K | ﹤0.01% | 3005 |
|
|
2022
Q2 | $513K | Buy |
173,753
+53,856
| +45% | +$283K | ﹤0.01% | 3041 |
|
|
2022
Q1 | $1.06M | Buy |
119,897
+79,046
| +193% | +$873K | 0.01% | 1986 |
|
|
2021
Q4 | $656K | Sell |
40,851
-7,229
| -15% | -$136K | 0.01% | 2240 |
|
|
2021
Q3 | $1.01M | Buy |
48,080
+35,073
| +270% | +$845K | 0.01% | 1523 |
|
|
2021
Q2 | $349K | Buy |
13,007
+419
| +3% | +$12.3K | ﹤0.01% | 2240 |
|
|
2021
Q1 | $401K | Sell |
12,588
-2,837
| -18% | -$68.9K | 0.01% | 2084 |
|
|
2020
Q4 | $353K | Sell |
15,425
-10,182
| -40% | -$234K | ﹤0.01% | 1958 |
|
|
2020
Q3 | $645K | Sell |
25,607
-44,669
| -64% | -$1.22M | 0.01% | 1591 |
|
|
2020
Q2 | $1.96M | Buy |
70,276
+69,850
| +16,397% | +$1.21M | 0.03% | 803 |
|
|
2020
Q1 | $2K | Sell |
426
-40,736
| -99% | -$370K | ﹤0.01% | 2110 |
|
|
2019
Q4 | $448K | Buy |
41,162
+34,462
| +514% | +$341K | 0.01% | 1609 |
|
|
2019
Q3 | $85K | Sell |
6,700
-54,801
| -89% | -$789K | ﹤0.01% | 1966 |
|
|
2019
Q2 | $1.04M | Buy |
61,501
+45,934
| +295% | +$789K | 0.02% | 1017 |
|
|
2019
Q1 | $280K | Buy |
15,567
+4,419
| +40% | +$76.4K | 0.01% | 1554 |
|
|
2018
Q4 | $142K | Sell |
11,148
-8,310
| -43% | -$139K | 0.01% | 1660 |
|
|
2018
Q3 | $417K | Buy |
19,458
+14,586
| +299% | +$311K | 0.02% | 953 |
|
|
2018
Q2 | $101K | Sell |
4,872
-20,440
| -81% | -$460K | 0.01% | 1534 |
|
|
2018
Q1 | $637K | Buy |
25,312
+18,416
| +267% | +$447K | 0.04% | 670 |
|
|
2017
Q4 | $131K | Buy |
6,896
+6,796
| +6,796% | +$127K | 0.01% | 1641 |
|
|
2017
Q3 | $2K | Sell |
100
-5,063
| -98% | -$87.7K | ﹤0.01% | 1813 |
|
|
2017
Q2 | $90K | Buy |
5,163
+4,071
| +373% | +$77.7K | 0.01% | 1467 |
|
|
2017
Q1 | $20K | Buy |
1,092
+943
| +633% | +$18.2K | ﹤0.01% | 1544 |
|
|
2016
Q4 | $3K | Buy |
+149
| New | +$3.75K | ﹤0.01% | 1680 |
|
Other funds holding MGNX
BG
AC
FLSM
WA
Cubist Systematic Strategies's MGNX Position: Q3 2025 in Review
Cubist Systematic Strategies reduced its MacroGenics (MGNX) stake by 69% in Q3 2025, selling an estimated $393K and leaving 109,226 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #2675.
Cubist Systematic Strategies first reported a position in MGNX in Q4 2016 and has held it in 31 quarters since. The position peaked at $1.96M in Q2 2020. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.
- Cubist Systematic Strategies held 109,226 shares of MacroGenics worth $184K as of Q3 2025.
- Cubist Systematic Strategies sold 242,879 MacroGenics shares in Q3 2025, an estimated $393K.
- MacroGenics made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2675 holding.
- Cubist Systematic Strategies first reported a position in MacroGenics in Q4 2016 and has held it in 31 quarters since.
- Cubist Systematic Strategies's MacroGenics position peaked at $1.96M in Q2 2020.
- 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.